ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

3.71
Delayed Data
As of Feb 22
 -0.02 / -0.54%
Today’s Change
3.33
Today|||52-Week Range
7.88
-10.39%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Cooper Laurence James Neil
Chief Executive Officer
Sale5/05/2017132,000$7.12$939.8K-47.89%
Belbel Caesar J
Sale12/30/201731,450$4.14$130.2K-16.44%
Lebel Francois /ziopharm/
Executive Vice President-Research & Development
Sale12/30/201731,450$4.14$130.2K-16.44%
Cooper Laurence James Neil
Chief Executive Officer
Sale12/30/201726,178$4.14$108.4K-16.44%
Belbel Caesar J
Sale6/01/201716,666$6.11$101.8K-39.28%
Belbel Caesar J
Sale12/31/201721,667$4.14$89.7K-16.44%
Lebel Francois /ziopharm/
Executive Vice President-Research & Development
Sale12/31/201721,667$4.14$89.7K-16.44%
Fowler Wyche Jr
Director
Sale6/12/201713,980$5.47$76.5K-32.18%
Weiser Michael
Director
Sale6/12/201713,300$5.47$72.8K-32.18%
Brennan Murray F
Director
Sale6/12/201713,300$5.47$72.8K-32.18%
Page of 4